COVID Vaccine Causing Myocarditis “More Common Than Previously Thought”: Swiss Study

BASEL, SWITZERLAND — Vaccine-associated myocardial infarction is “more common than previously thought” according to a peer-reviewed study published in European Journal of Heart Failure on July 20.

The study was conducted by scientists at the Department of Cardiology and Cardiovascular Research Institute Basel (CRIB) at the University Hospital Basel in Switzerland. The team examined hospital employees who were scheduled to undergo booster vaccination with Moderna’s mRNA-1273 injection. The investigation included 777 subjects, of which 69.5 percent were female and 30.5 percent male. The median age was 37.

“mRNA-1273 booster vaccination-associated elevation of markers of myocardial injury occurred in about one out of 35 persons (2.8%), a greater incidence than estimated in meta-analyses of hospitalized cases with myocarditis (estimated incidence 0.0035%) after the second vaccination,” the authors write.

According to the study, myocardial injury was significantly more common in women than in men (3.7 percent versus 0.8 percent).

“Additional active surveillance studies are needed to externally validate two specific findings of this study: the even higher rate of mRNA-1273 booster vaccination associated myocardial injury overall, and particularly in women,” the study concludes.

Many physicians and researchers – including Florida Surgeon General Joseph Ladapo – have warned about myocarditis and other heart-related disorders associated with COVID-19 vaccination.

A recent autopsy study led by world-renowned cardiologist Dr. Peter McCullough found that nearly 74 percent of deaths following COVID-19 vaccination could be linked to the mRNA shots. The preprint of the study was deleted from The Lancet’s servers within 24 hours of submission.